Abstract
This article describes electrical and pharmacologic cardioversion for atrial fibrillation and discusses indications for cardioversion and management of pericardioversion anticoagulation. Finally, management strategies are offered for immediate recurrence of atrial fibrillation and cardioversion failure.
MeSH terms
-
Anti-Arrhythmia Agents / therapeutic use*
-
Anticoagulants / therapeutic use
-
Atrial Fibrillation / complications
-
Atrial Fibrillation / physiopathology
-
Atrial Fibrillation / therapy*
-
Cardiac Catheterization / instrumentation
-
Cardiac Catheterization / methods
-
Defibrillators
-
Electric Countershock / instrumentation
-
Electric Countershock / methods*
-
Equipment Design
-
Heart Rate / physiology*
-
Humans
-
Thromboembolism / etiology
-
Thromboembolism / prevention & control
-
Treatment Outcome
Substances
-
Anti-Arrhythmia Agents
-
Anticoagulants